Introduction
Background
Methods
Design and sample
Data collection procedure
Research intervention
Course Content | Methodology | Hours |
---|---|---|
Session 1 •Pain Definition •Pain Physiology •Types of Pain | •Lecture •Group iscussion | •2 hours |
Session 2 •Pain Assessment and Reassessment Tools •Pain Management (non-pharmacological and pharmacological, barriers to effective pain management, and patient-controlled analgesia) | •Group discussion •Hands-on activity •Demonstration and re-demonstration (B. Braun automated infusion pumps) | •4 hours |
Session 3 •Respiratory and Cardiac complications •Reversal Agents | •Lecture •Case study •Adult Airway Management Trainer (Airway Larry) | •4 hours |
Session 4 •Patient Monitoring and Documentation •Speaking Up for Patients’ Rights •Patient/Family Education | •Lecture •Group discussion •Case study | •2 hours |
Measures
Knowledge and attitudes survey regarding pain
Satisfaction and self-confidence in learning
Self-efficacy scale for clinical skills
Ethical considerations
Data analysis
Results
Demographics’ characteristics
Variable (Range) | n (%) or M (SD) |
---|---|
Sex | |
Male | 12 (9.6) |
Female | 113 (90.4) |
Years of Experience in Nursing | 6.20 (3.23) |
Level of Nursing Education | |
Diploma | 87 (69.6) |
BSN | 38 (30.4) |
Working Unit | |
Critical | 37 (29.6) |
General | 79 (63.2) |
Outpatient | 9 (7.2) |
Previous Pain Management Training | |
Yes | 62 (49.6) |
No | 63 (50.4) |
No. Item Content | Correct Responses | P-value | ||||
---|---|---|---|---|---|---|
Pre-test | Post-test | |||||
N | % | N | % | |||
1. | Because their nervous systems are underdeveloped, children under 2 years of age have decreased pain sensitivity and limited memory of painful experiences | 55 | 44 | 78 | 62.4 | .002** |
2. | Vital signs are always reliable indicators of the intensity of a patient’s pain | 30 | 24 | 60 | 48 | <.001** |
3. | Patients who can be distracted from pain usually do not have severe pain | 61 | 48 | 69 | 55.2 | .266 |
4. | Patients may sleep despite severe pain | 31 | 24.8 | 53 | 42.4 | .002** |
5. | Aspirin and other nonsteroidal anti-inflammatory agents are not effective analgesics for painful bone metastases | 53 | 42.4 | 74 | 59.2 | .003** |
6. | Respiratory depression rarely occurs in patients who have been receiving stable doses of opioids over several months | 90 | 72 | 81 | 64.4 | .171 |
7. | Combining analgesics that work by different mechanisms (e.g., combining an NSAID with an opioid) may result in better pain control with fewer side effects than using a single analgesic agent | 85 | 68 | 83 | 66.4 | .790 |
8. | The usual duration of analgesia of 1–2 mg of morphine IV is 4–5 hours. | 49 | 39.2 | 56 | 44.8 | .260 |
9. | Opioids should not be used in patients with a history of substance abuse | 36 | 28.8 | 33 | 26.4 | .663 |
10. | Elderly patients cannot tolerate opioids for pain relief | 82 | 65.6 | 90 | 72.0 | .209 |
11. | Patients should be encouraged to endure as much pain as possible before using an opioid | 43 | 34.4 | 49 | 39.2 | .425 |
12. | Children less than 11 years old cannot reliably report pain, so clinicians should rely solely on the parent’s assessment of the child’s pain intensity | 68 | 54.4 | 69 | 55.2 | .900 |
13. | Patients’ spiritual beliefs may lead them to think pain and suffering are necessary | 74 | 59.2 | 91 | 72.8 | .006** |
14. | After an initial dose of an opioid analgesic is given, subsequent doses should be adjusted following the individual patient’s response | 105 | 84 | 104 | 83.2 | .882 |
15. | Giving patients sterile water by injection (placebo) is a useful test to determine if the pain is real | 30 | 24 | 23 | 18.4 | .251 |
16. | Vicodin (hydrocodone 5 mg + acetaminophen 300 mg) PO is approximately equal to 5–10 mg of morphine PO | 68 | 54.4 | 82 | 65.6 | .052 |
17. | If the source of the patient’s pain is unknown, opioids should not be used during the pain evaluation period, as this could mask the ability to correctly diagnose the cause of pain | 23 | 18.4 | 23 | 18.4 | .053 |
18. | Anticonvulsant drugs such as gabapentin (Neurontin) produce optimal pain relief after a single dose | 65 | 52 | 60 | 48.0 | .595 |
19. | Benzodiazepines are not effective pain relievers and are rarely recommended as part of an analgesic regiment | 77 | 61.6 | 82 | 65.6 | .433 |
20. | Narcotic/opioid addiction is defined as a chronic neurobiological disease characterized by behaviors that include one or more of the following: impaired control over drug use, compulsive use, continued use despite harm, and craving | 112 | 89.6 | 114 | 91.2 | .657 |
21. | The term “equianalgesia” means approximately equal analgesia and is used when referring to the doses of various analgesics that provide approximately the same amount of pain relief | 81 | 64.8 | 104 | 83.2 | <.001** |
22. | Sedation assessment is recommended during opioid pain management because excessive sedation precedes opioid-induced respiratory depression | 115 | 92 | 117 | 93.6 | .469 |
23. | The recommended route of administration of opioid analgesics for patients with persistent cancer-related pain is oral | 50 | 40 | 34 | 27.2 | .023* |
24. | The recommended route of administration of opioid analgesics for patients with brief, severe pain from sudden onset such as trauma or postoperative pain is IV. | 88 | 70.4 | 106 | 84.8 | .003** |
25. | Which of the following analgesic medications is considered the drug of choice for the treatment of prolonged moderate to severe pain for cancer patients? Morphine | 105 | 84 | 109 | 87.2 | .338 |
26. | A 30 mg dose of oral morphine is approximately equivalent to Morphine 10 mg IV | 53 | 42.4 | 59 | 47.2 | .408 |
27. | Analgesics for postoperative pain should initially be given around the clock on a fixed schedule. | 89 | 71.2 | 108 | 86.4 | .002** |
28. | A patient with persistent cancer pain has been receiving daily opioid analgesics for 2 months. Yesterday, the patient was receiving morphine 200 mg/hour intravenously. Today he has been receiving 250 mg/hour intravenously. The likelihood of the patient developing clinically significant respiratory depression in the absence of new comorbidity is less than 1%. | 36 | 28.8 | 30 | 24.0 | .416 |
29. | The most likely reason a patient with pain would request increased doses of pain medication is related to experiencing increased pain | 81 | 64.8 | 60 | 48.0 | .008** |
30. | Which of the following is useful for the treatment of cancer pain? Ibuprofen, Hydromorphone, Gabapentin, all of the above. | 65 | 52 | 65 | 52.8 | .794 |
31. | The most accurate judge of the intensity of the patient’s pain is the patient him/herself. | 72 | 57.6 | 79 | 63.2 | .269 |
32. | Which of the following describes the best approach for cultural considerations in caring for patients in pain: Patients should be individually assessed to determine cultural influences. | 69 | 55.2 | 69 | 55.2 | 1.00 |
33. | How likely is it that patients who develop pain already have an alcohol and/or drug abuse problem? 5–15% | 41 | 32.8 | 53 | 42.4 | .115 |
34. | The time to peak effect for morphine given IV is 15 minutes. | 87 | 69.6 | 118 | 89.6 | <.001** |
35. | The time to peak effect for morphine given orally is 1–2 hours | 70 | 56 | 67 | 53.6 | .719 |
36. | Following the abrupt discontinuation of opioids, physical dependence is manifested by the following: sweating, yawning, diarrhea, and agitation with patients when the opioid is abruptly discontinued | 35 | 28 | 41 | 32.8 | .398 |
37. | Which statement is true regarding opioid-induced respiratory depression: Obstructive sleep apnoea is an important risk factor. | 54 | 43.2 | 51 | 40.8 | .797 |
38a. | Patient A: Andrew is 25 years old and this is his first day following abdominal surgery. As you enter his room, he smiles at you and continues talking and joking with his visitor. Your assessment reveals the following information: BP = 120/80, HR = 80. He rates his pain as 8. On the patient’s record, you must mark his pain on the scale below. Circle the number that represents your assessment of Andrew’s pain. | 35 | 28 | 36 | 28.8 | .880 |
38b. | Your assessment, above, was made 2 hours after he received morphine 2 mg IV. Half-hourly pain ratings following the injection ranged from 6 to 8, and he had no clinically significant respiratory depression, sedation, or other side effects. He has: Administer morphine 3 mg IV now | 10 | 8 | 9 | 7.2 | .820 |
39a. | Patient B: Robert is 25 years old and this is his first day following abdominal surgery. As you enter his room, he is lying quietly in bed and grimaces as he turns in bed. Your assessment reveals the following information: BP = 120/80; HR = 80; R = 18. He rates his pain as 8. On the patient’s record, you must mark his pain on the scale below. Circle the number that represents your assessment of Robert’s pain. | 50 | 40 | 50 | 40 | 1.00 |
39b. | Your assessment, above, was made 2 hours after he received morphine 2 mg IV. Half-hourly pain ratings following the injection ranged from 6 to 8, and he had no clinically significant respiratory depression, sedation, or other untoward side effects: administer morphine 3 mg IV now | 17 | 13.6 | 16 | 12.8 | .854 |
Mean differences between pre and post the pain management education
Knowledge and attitudes | M (SD) | t | p |
---|---|---|---|
Post-pain management education | 22.2 (5.09) | 2.866 | .005* |
Pre-pain management education | 20.3 (4.80) |
Knowledge and Attitudes regarding Pain | |||||||
---|---|---|---|---|---|---|---|
Variable | Pre-Pain Management Education | Post Pain Management Education | |||||
(Possible range) | (0–41) | (0–41) | |||||
Range | M (SD) | t, F, or r | p | M (SD) | t, F, or r | p | |
Sex | Male Female | 21.2 (2.82) 20.2 (4.95) | 0.643 | .521 | 21.0 (5.60) 22.3 (5.04) | 0.842 | .401 |
Years of Experience | 1–15 | −.002 | .983 | −.047 | .602 | ||
Level of Nursing Education | Diploma BSN | 19.5 (4.22) 22.2 (5.50) | 3.057 | .003* | 22.3 (5.50) 22.0 (4.12) | 0.295 | .768 |
Working Unit | Critical General Outpatient | 21.4 (6.00) 19.7 (4.15) 20.9 (4.29) | 1.672 | .192 | 23.1 (5.79) 21.7 (4.65) 22.3 (5.77) | 0.995 | .373 |
Previous Pain Management Training | Yes No | 20.2 (3.48) 20.5 (5.82) | 0.330 | .742 | 22.5 (5.10) 21.84 (5.11) | 0.746 | .457 |
Self-confidence, self-learning efficacy, and satisfaction with the intervention
Variables (possible range) | Range | Mean (SD) |
---|---|---|
Self-confidence (8–40) | 18–40 | 35.6 (4.68) |
Self-learning efficacy (12–60) | 25–60 | 52.9 (7.70) |
Satisfaction (5–25) | 10–25 | 22.2 (3.24) |